Global POC Infectious Diseases 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12246801

Publication Date:

December 24, 2024

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global POC Infectious Diseases market size was valued at US$ million in 2023. With growing demand in downstream market, the POC Infectious Diseases is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global POC Infectious Diseases market. POC Infectious Diseases are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of POC Infectious Diseases. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the POC Infectious Diseases market.
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
Key Features:
The report on POC Infectious Diseases market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the POC Infectious Diseases market. It may include historical data, market segmentation by Type (e.g., Flu, Adenovirus), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the POC Infectious Diseases market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the POC Infectious Diseases market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the POC Infectious Diseases industry. This include advancements in POC Infectious Diseases technology, POC Infectious Diseases new entrants, POC Infectious Diseases new investment, and other innovations that are shaping the future of POC Infectious Diseases.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the POC Infectious Diseases market. It includes factors influencing customer ' purchasing decisions, preferences for POC Infectious Diseases product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the POC Infectious Diseases market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting POC Infectious Diseases market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the POC Infectious Diseases market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the POC Infectious Diseases industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the POC Infectious Diseases market.
麻豆原创 Segmentation:
POC Infectious Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Segmentation by application
Hospital& Clinics
Clinical Diagnostic Laboratories
麻豆原创care Settings
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Cepheid
Diamedix
Diasorin
Eiken Chemical
Enzo Biochem

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global POC Infectious Diseases 麻豆原创 Size 2019-2030
2.1.2 POC Infectious Diseases 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 POC Infectious Diseases Segment by Type
2.2.1 Flu
2.2.2 Adenovirus
2.2.3 Malaria
2.2.4 Streptococcal Bacteremia
2.2.5 Tuberculosis (TB)
2.2.6 Occult Blood
2.2.7 HIV
2.3 POC Infectious Diseases 麻豆原创 Size by Type
2.3.1 POC Infectious Diseases 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global POC Infectious Diseases 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 POC Infectious Diseases Segment by Application
2.4.1 Hospital& Clinics
2.4.2 Clinical Diagnostic Laboratories
2.4.3 麻豆原创care Settings
2.5 POC Infectious Diseases 麻豆原创 Size by Application
2.5.1 POC Infectious Diseases 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global POC Infectious Diseases 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 POC Infectious Diseases 麻豆原创 Size by Player
3.1 POC Infectious Diseases 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global POC Infectious Diseases Revenue by Players (2019-2024)
3.1.2 Global POC Infectious Diseases Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global POC Infectious Diseases Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POC Infectious Diseases by Regions
4.1 POC Infectious Diseases 麻豆原创 Size by Regions (2019-2024)
4.2 Americas POC Infectious Diseases 麻豆原创 Size Growth (2019-2024)
4.3 APAC POC Infectious Diseases 麻豆原创 Size Growth (2019-2024)
4.4 Europe POC Infectious Diseases 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa POC Infectious Diseases 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas POC Infectious Diseases 麻豆原创 Size by Country (2019-2024)
5.2 Americas POC Infectious Diseases 麻豆原创 Size by Type (2019-2024)
5.3 Americas POC Infectious Diseases 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC POC Infectious Diseases 麻豆原创 Size by Region (2019-2024)
6.2 APAC POC Infectious Diseases 麻豆原创 Size by Type (2019-2024)
6.3 APAC POC Infectious Diseases 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe POC Infectious Diseases by Country (2019-2024)
7.2 Europe POC Infectious Diseases 麻豆原创 Size by Type (2019-2024)
7.3 Europe POC Infectious Diseases 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa POC Infectious Diseases by Region (2019-2024)
8.2 Middle East & Africa POC Infectious Diseases 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa POC Infectious Diseases 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global POC Infectious Diseases 麻豆原创 Forecast
10.1 Global POC Infectious Diseases Forecast by Regions (2025-2030)
10.1.1 Global POC Infectious Diseases Forecast by Regions (2025-2030)
10.1.2 Americas POC Infectious Diseases Forecast
10.1.3 APAC POC Infectious Diseases Forecast
10.1.4 Europe POC Infectious Diseases Forecast
10.1.5 Middle East & Africa POC Infectious Diseases Forecast
10.2 Americas POC Infectious Diseases Forecast by Country (2025-2030)
10.2.1 United States POC Infectious Diseases 麻豆原创 Forecast
10.2.2 Canada POC Infectious Diseases 麻豆原创 Forecast
10.2.3 Mexico POC Infectious Diseases 麻豆原创 Forecast
10.2.4 Brazil POC Infectious Diseases 麻豆原创 Forecast
10.3 APAC POC Infectious Diseases Forecast by Region (2025-2030)
10.3.1 China POC Infectious Diseases 麻豆原创 Forecast
10.3.2 Japan POC Infectious Diseases 麻豆原创 Forecast
10.3.3 Korea POC Infectious Diseases 麻豆原创 Forecast
10.3.4 Southeast Asia POC Infectious Diseases 麻豆原创 Forecast
10.3.5 India POC Infectious Diseases 麻豆原创 Forecast
10.3.6 Australia POC Infectious Diseases 麻豆原创 Forecast
10.4 Europe POC Infectious Diseases Forecast by Country (2025-2030)
10.4.1 Germany POC Infectious Diseases 麻豆原创 Forecast
10.4.2 France POC Infectious Diseases 麻豆原创 Forecast
10.4.3 UK POC Infectious Diseases 麻豆原创 Forecast
10.4.4 Italy POC Infectious Diseases 麻豆原创 Forecast
10.4.5 Russia POC Infectious Diseases 麻豆原创 Forecast
10.5 Middle East & Africa POC Infectious Diseases Forecast by Region (2025-2030)
10.5.1 Egypt POC Infectious Diseases 麻豆原创 Forecast
10.5.2 South Africa POC Infectious Diseases 麻豆原创 Forecast
10.5.3 Israel POC Infectious Diseases 麻豆原创 Forecast
10.5.4 Turkey POC Infectious Diseases 麻豆原创 Forecast
10.5.5 GCC Countries POC Infectious Diseases 麻豆原创 Forecast
10.6 Global POC Infectious Diseases Forecast by Type (2025-2030)
10.7 Global POC Infectious Diseases Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott POC Infectious Diseases Product Offered
11.1.3 Abbott POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Meridian Bioscience
11.2.1 Meridian Bioscience Company Information
11.2.2 Meridian Bioscience POC Infectious Diseases Product Offered
11.2.3 Meridian Bioscience POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Meridian Bioscience Main Business Overview
11.2.5 Meridian Bioscience Latest Developments
11.3 Orasure Technologies
11.3.1 Orasure Technologies Company Information
11.3.2 Orasure Technologies POC Infectious Diseases Product Offered
11.3.3 Orasure Technologies POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Orasure Technologies Main Business Overview
11.3.5 Orasure Technologies Latest Developments
11.4 Trinity Biotech
11.4.1 Trinity Biotech Company Information
11.4.2 Trinity Biotech POC Infectious Diseases Product Offered
11.4.3 Trinity Biotech POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Trinity Biotech Main Business Overview
11.4.5 Trinity Biotech Latest Developments
11.5 Beckman Coulter/ Danaher
11.5.1 Beckman Coulter/ Danaher Company Information
11.5.2 Beckman Coulter/ Danaher POC Infectious Diseases Product Offered
11.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Beckman Coulter/ Danaher Main Business Overview
11.5.5 Beckman Coulter/ Danaher Latest Developments
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Information
11.6.2 Becton Dickinson POC Infectious Diseases Product Offered
11.6.3 Becton Dickinson POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Becton Dickinson Main Business Overview
11.6.5 Becton Dickinson Latest Developments
11.7 Biomerieux
11.7.1 Biomerieux Company Information
11.7.2 Biomerieux POC Infectious Diseases Product Offered
11.7.3 Biomerieux POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Biomerieux Main Business Overview
11.7.5 Biomerieux Latest Developments
11.8 Bio-Rad
11.8.1 Bio-Rad Company Information
11.8.2 Bio-Rad POC Infectious Diseases Product Offered
11.8.3 Bio-Rad POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Bio-Rad Main Business Overview
11.8.5 Bio-Rad Latest Developments
11.9 Cepheid
11.9.1 Cepheid Company Information
11.9.2 Cepheid POC Infectious Diseases Product Offered
11.9.3 Cepheid POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Cepheid Main Business Overview
11.9.5 Cepheid Latest Developments
11.10 Diamedix
11.10.1 Diamedix Company Information
11.10.2 Diamedix POC Infectious Diseases Product Offered
11.10.3 Diamedix POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Diamedix Main Business Overview
11.10.5 Diamedix Latest Developments
11.11 Diasorin
11.11.1 Diasorin Company Information
11.11.2 Diasorin POC Infectious Diseases Product Offered
11.11.3 Diasorin POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Diasorin Main Business Overview
11.11.5 Diasorin Latest Developments
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Information
11.12.2 Eiken Chemical POC Infectious Diseases Product Offered
11.12.3 Eiken Chemical POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Eiken Chemical Main Business Overview
11.12.5 Eiken Chemical Latest Developments
11.13 Enzo Biochem
11.13.1 Enzo Biochem Company Information
11.13.2 Enzo Biochem POC Infectious Diseases Product Offered
11.13.3 Enzo Biochem POC Infectious Diseases Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Enzo Biochem Main Business Overview
11.13.5 Enzo Biochem Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.